-360x180.jpg)
Monoclonal antibodies have a multitude of uses – they can treat viral diseases such as coronavirus disease 2019 (COVID-19), be used in diagnostic tests such...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the coronavirus disease 2019 (COVID-19), is readily communicable between humans. Recent...
Since 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have been an increasing threat globally. The first variant (the Alpha variant) was discovered in...
The emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) adversely impacted global health and economics. The...
-360x180.jpg)
The coronavirus 2019 (COVID-19) pandemic has caused over 254 million confirmed cases and more than 5.1 million deaths worldwide as of 17th November 2021. Approximately...
As new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, reports of vaccine breakthrough infections and reinfections rise, with one...
Scientists from the University of North Carolina have recently conducted computational modeling studies to predict the structure and immune escape ability of spike receptor-binding domain...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China in December 2019, leading to a worldwide outbreak of coronavirus disease...
The recently identified Omicron variant is the cause behind a surge of coronavirus disease 2019 (COVID-19) cases and hospitalizations in the last few months of...
In a recent study published in the United States Centers for Disease Control and Prevention (CDC) Emerging Infectious Diseases journal, researchers investigate the spread and...
A recent review article published in the journal Advanced Science reviewed the features of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants. Using a...
In a recent study posted to the bioRxiv* preprint server, researchers proposed and constructed receptor-blocking conserved non-neutralizing antibodies (ReconnAbs) effective towards the severe acute respiratory syndrome...
